Skip to content

Comparison Between Mini-midline and the Peripheral Intravenous Catheter

Comparison Between the Long (Mini-midline) and the Short Catheter (Peripheral Intravenous Catheter) in the Reduction of Venipunctures During Hospital Stay: a Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06290284
Acronym
INSERT/2022
Enrollment
294
Registered
2024-03-04
Start date
2023-09-25
Completion date
2023-12-28
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vascular Access Devices, Venous Puncture

Keywords

Vascular access, Emergency Department, Long Peripheral Catheter, Peripheral Intra-Venous Catheter

Brief summary

The goal of this randomized controlled trial is to investigate the difference between LPC (mini-midline) and PIVC (peripheral venous catheter) on the need of further venipuncture for blood withdrawal or placement of a new vascular access. The main questions it aims to answer are: * Whether the number of patients with LPC and PIVC differ in terms of repeated venipunctures; * Whether the number of patients with LPC and PIVC differ in terms of adverse events associated with the use of such vascular catheters. Researchers will compare the proportion of patients with repeated venipunctures between LPC and PIVC arms.

Detailed description

A standard peripheral intravenous catheter (PIVC) or a mini-midline (LPC) will be placed according to routine clinical indications (i.e., for blood withdrawal and IV drug therapy) in patients seeking care at the Emergency Department. On admission at the Emergency Department triage desk, patients will be assigned a triage code according to clinical assessment by the triage nurse and will be evaluated as to the probability of being eventually admitted to hospital. Following enrollment, patients will be randomly assigned to receive LPC or PIVC. The follow-up period begins after catheter placement and continues through transfer to a hospital ward. During this period of catheter management, the insertion site and dressing will be monitored.

Interventions

PROCEDURELong Peripheral Catheter

PowerGlide Pro™ Midline Catheter

PROCEDUREPeripheral Intra-Venous Catheter

Venflon™ Pro Safety Needle Protected IntraVenous Cannula

Sponsors

Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Masking description

The statistician will be provided an anonymized dataset.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age ≥ 18 years * High probability of hospital admission * Sufficient venous patrimony according to EA-DIVA scale score

Exclusion criteria

* Patients already having a venous access in place * Patients requiring life-saving treatments * Patients seeking ambulatory care * Patients unable to express informed consent

Design outcomes

Primary

MeasureTime frameDescription
Difference in proportionThe catheter will be evaluated within 24 hours after the placementDifference between the two study arms in the proportion of patients who required a venipuncture after insertion of the PIVC or the LPC.

Secondary

MeasureTime frameDescription
Adverse events associated with use of LPC and PIVCAdverse will be evaluated every 24 hours till the catheter removalNumber of adverse events (e.g., thrombophlebitis, extravasation, inflammation of the insertion site) monitored also using the Visual Infusion Phlebitis Score

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026